Universal fibronectin type III binding-domain libraries

Details for Australian Patent Application No. 2008287426 (hide)

Owner Protelix, Inc.

Inventors Kirk, Peter B.; Cappuccilli, Guido; Liston, David R.; Crea, Roberto; Shen, Randy; Hokanson, Craig A.

Agent FB Rice

Pub. Number AU-A-2008287426

PCT Pub. Number WO2009/023184

Priority 60/955,334 10.08.07 US; 61/075,107 24.06.08 US

Filing date 11 August 2008

Wipo publication date 19 February 2009

International Classifications

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C07K 14/78 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/023184 Priority application(s): WO2009/023184

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008287427-Cancer treatment using humanized antibodies that bind to EphB4

2008287421-Nitrogen containing bicyclic chemical entities for treating viral infections